During the U.S. healthcare deliberations, the words invention, technology, diagnostics, and wellness were mentioned rarely, if ever. No one said “revolution in healthcare” and yet a healthcare revolution is underway. Never before could a physician peer into the body, blood, or DNA of a patient and “see” the risk of disease for that person or “see” a disease at such an early stage that intervention might be crucial. That vision defines personalized medicine, which includes actionable measurements of genotype and phenotype – DNA and proteins.
For the inaugural symposium, Gold Lab invited medical and scientific thought leaders and stakeholders to debate and inform each other and the audience on how best to facilitate the most timely transformation of medicine. “Our motivation is simple,” said Dr. Larry Gold, Professor, MCDB, University of Colorado and CEO of SomaLogic, “Scientists are responsible for innovations; scientists also must participate in discussions that enable the timely use of those innovations. An informed citizenry is at the heart of an improved healthcare system.”